IgA2 Activators
IgA2 activation involves a complex interplay of various immune factors, cytokines, and signaling pathways, making it distinct from classical small molecule-driven activations. The immune system's regulation of IgA2 involves a series of events triggered by encounters with pathogens or antigens. The mentioned chemicals, although not conventional activators, influence immune responses and signaling cascades that intricately modulate B-cell functions, impacting IgA2 expression. The immune system's ability to discriminate between harmful and harmless stimuli, and subsequently initiate specific responses, is fundamental to IgA2 activation.
In conclusion, the activation of IgA2 is a dynamic process tightly integrated into the broader context of immune responses. The mentioned chemicals influence various immune signaling pathways, and their potential impact on IgA2 expression is embedded in the intricate network of the immune system's regulation. This unique characteristic emphasizes the complexity of IgA2 activation, driven by a sophisticated interplay of immune factors rather than conventional chemical activators.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Imiquimod | 99011-02-6 | sc-200385 sc-200385A | 100 mg 500 mg | $67.00 $284.00 | 6 | |
Imiquimod, a TLR7 agonist, activates immune responses by modulating cytokine production. Its influence on the immune milieu may indirectly affect IgA2 expression, as TLR7 engagement can lead to intricate signaling events impacting B-cell functions and antibody production. | ||||||
Polyinosinic acid - polycytidylic acid sodium salt, double-stranded | 42424-50-0 | sc-204854 sc-204854A | 10 mg 100 mg | $139.00 $663.00 | 2 | |
Poly I:C, a synthetic analog of double-stranded RNA, activates TLR3 and induces antiviral responses. While not a direct IgA2 activator, its impact on immune signaling pathways can modulate B-cell responses, potentially affecting IgA2 expression during viral infections or other immune challenges. | ||||||
Lipopolysaccharide, E. coli O55:B5 | 93572-42-0 | sc-221855 sc-221855A sc-221855B sc-221855C | 10 mg 25 mg 100 mg 500 mg | $98.00 $171.00 $425.00 $1560.00 | 12 | |
LPS, a TLR4 agonist, activates immune responses. Its signaling cascade involves intricate pathways affecting B-cell activation. While not a traditional chemical, LPS influences immune responses and may indirectly impact IgA2 production by triggering immune cascades involving various cytokines and immune cells. | ||||||
R-848 | 144875-48-9 | sc-203231 sc-203231A sc-203231B sc-203231C | 5 mg 25 mg 100 mg 500 mg | $102.00 $306.00 $510.00 $1559.00 | 12 | |
R848, a TLR7/8 agonist, stimulates immune responses by modulating cytokine production. Its impact on immune signaling pathways may indirectly affect IgA2 expression, as TLR7/8 activation leads to intricate signaling events affecting B-cell functions and antibody production. | ||||||